The WHO has released a statement regarding the initiation of a trial for the hepatitis B birth dose vaccine in Guinea-Bissau.
The World Health Organization (WHO) has issued a statement regarding the upcoming trial of a hepatitis B birth dose vaccine in Guinea-Bissau. This initiative aims to improve public health outcomes related to hepatitis B, a significant concern in the region. While specific details about the trial's methodology or timeline were not provided, the announcement underscores the WHO's commitment to combating hepatitis B and enhancing vaccination efforts in affected areas.
Personalise this feed
Your specialty. Your sources. Your digest.
All set up in under 2 minutes.
Personalise this feed
Your specialty. Your sources. Your digest.
All set up in under 2 minutes.